| LONZA N | 577.40 / +0.45% |
| Date/Time | 05/07 / 17:30 |
| Chg. / Chg.(%) | 2.60 / +0.45% |
| Bid | - / 40 |
| Ask | - / 20 |
| Open | 575.40 |
| Previous Close | 574.80 |
| High | 577.40 |
| Low | 564.60 |
| Volume [CHF] | 75,056,927.40 |
| Volume [Units] | 130,827 |
| Price fixings | 4156 |
| ISIN | CH0013841017 |
| Security | LONN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 523.600 |  |
|
| SIX Swiss Ex.. | 577.40 | |
130,827 |
| Cboe Europe .. | 576.60 | |
30,006 |
| Cboe Europe .. | 577.40 | |
16,166 |
| London Inter.. | 571.80 | |
10,662 |
| Turquoise | 576.40 | |
4,528 |
| Nasdaq Other.. | 637.8800 | |
2 |
| Mexico | 12,110.20 |  |
360 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Affinia Therapeutics Closes $110 Million Series B Financing
05/03/2021 / 12:30 - GlobeNewswire - aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
04/14/2021 / 14:00 - GlobeNewswire - Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
04/01/2021 / 14:00 - GlobeNewswire - Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
03/12/2021 / 07:00 - GlobeNewswire - Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
03/03/2021 / 14:00 - GlobeNewswire
Real-time